Display options
Cite
Ding WX, Dong YB, Ding N, et al. Adiponectin protects rat heart from left ventricular remodeling induced by chronic intermittent hypoxia via inhibition of TGF-β/smad2/3 pathway. J Thorac Dis. 2014;6(9):1278-84doi: 10.3978/j.issn.2072-1439.2014.07.44.
Ding, W. X., Dong, Y. B., Ding, N., Zhang, X. F., Zhang, S. J., Zhang, X. L., Liu, J. N., & Lu, G. (2014). Adiponectin protects rat heart from left ventricular remodeling induced by chronic intermittent hypoxia via inhibition of TGF-β/smad2/3 pathway. Journal of thoracic disease, 6(9), 1278-84. https://doi.org/10.3978/j.issn.2072-1439.2014.07.44
Ding, Wen-Xiao, et al. "Adiponectin protects rat heart from left ventricular remodeling induced by chronic intermittent hypoxia via inhibition of TGF-β/smad2/3 pathway." Journal of thoracic disease vol. 6,9 (2014): 1278-84. doi: https://doi.org/10.3978/j.issn.2072-1439.2014.07.44
Ding WX, Dong YB, Ding N, Zhang XF, Zhang SJ, Zhang XL, Liu JN, Lu G. Adiponectin protects rat heart from left ventricular remodeling induced by chronic intermittent hypoxia via inhibition of TGF-β/smad2/3 pathway. J Thorac Dis. 2014 Sep;6(9):1278-84. doi: 10.3978/j.issn.2072-1439.2014.07.44. PMID: 25276370; PMCID: PMC4178112.
Copy Download .nbib Format: NLM
Share it on

J Thorac Dis. 2014 Sep;6(9):1278-84. doi: 10.3978/j.issn.2072-1439.2014.07.44.

Adiponectin protects rat heart from left ventricular remodeling induced by chronic intermittent hypoxia via inhibition of TGF-β/smad2/3 pathway.

Journal of thoracic disease

Wen-Xiao Ding, Yan-Bin Dong, Ning Ding, Xiao-Feng Zhang, Shi-Jiang Zhang, Xi-Long Zhang, Jian-Nan Liu, Gan Lu

Affiliations

  1. 1 Department of Respiratory Medicine, 2 Department of Cardiothoracic Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China ; 3 Department of Respiratory Diseases, Jiangsu Geriatric Hospital, Nanjing 210024, China.

PMID: 25276370 PMCID: PMC4178112 DOI: 10.3978/j.issn.2072-1439.2014.07.44

Abstract

OBJECTIVE: Obstructive sleep apnea syndrome (OSAS) is associated with many cardiovascular disorders. Chronic intermittent hypoxia (CIH) is the primary player in OSAS of the many associated factors. This study was in order to investigate the effects of the Adiponectin (Ad) on left ventricular remodeling induced by CIH.

METHODS: Forty-five rats were randomly divided into three groups: normal control (NC) group, CIH group and CIH plus Ad supplemented (CIH + Ad) group. After 35 days' CIH exposure, masson analysis was used to detect the left ventricular fibrosis and western blot was used to measure the protein expression of collagen I, collagen III and TGF-β/smad2/3 pathway. Gene analysis by RT-PCR was used to study the MMP2 and TIMP2.

RESULTS: After CIH exposure, the fibrosis of left ventricular in CIH group was significantly remarkable than that in both NC and CIH + Ad groups (P<0.05), although statistical difference existed between NC and CIH + Ad groups (P<0.05). In addition, the protein expression of collagen I as well as collagen III and the ratio of mRNA levels of MMP2/TIMP2 were the highest in CIH group but the lowest in NC group, with CIH + Ad group in between. There was a significant difference among three groups (all P<0.05). The TGF-β/smad2/3 pathway was activated obviously in CIH group, but less noticeably in CIH + Ad group (P<0.05) with a significant difference in the two groups.

CONCLUSIONS: The present study showed that Ad could ameliorate the left ventricular remodeling induced by CIH via inhibition of the expression of TGF-β/smad2/3 pathway.

Keywords: Chronic intermittent hypoxia (CIH); adiponectin; left ventricular remodeling

References

  1. Annu Rev Cell Dev Biol. 2005;21:659-93 - PubMed
  2. Clin Psychopharmacol Neurosci. 2013 Aug;11(2):45-52 - PubMed
  3. J Card Fail. 2010 Jul;16(7):599-608 - PubMed
  4. Arterioscler Thromb Vasc Biol. 2008 May;28(5):863-70 - PubMed
  5. Circ Res. 2002 Mar 22;90(5):520-30 - PubMed
  6. J Cardiol. 2012 Dec;60(6):475-83 - PubMed
  7. Cell Signal. 2013 Jan;25(1):264-8 - PubMed
  8. Circ Res. 1991 Aug;69(2):483-90 - PubMed
  9. Mol Genet Metab. 2000 Sep-Oct;71(1-2):418-35 - PubMed
  10. Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):2005-10 - PubMed
  11. Am J Respir Crit Care Med. 2005 Oct 1;172(7):915-20 - PubMed
  12. Hypertens Res. 2010 Jun;33(6):579-86 - PubMed
  13. J Am Coll Cardiol. 2011 Jan 11;57(2):119-27 - PubMed
  14. J Appl Physiol (1985). 2008 Jan;104(1):218-23 - PubMed
  15. Biochem Biophys Res Commun. 1999 Apr 2;257(1):79-83 - PubMed
  16. Trends Cardiovasc Med. 2006 Jul;16(5):141-6 - PubMed
  17. Nat Med. 2005 Oct;11(10):1096-103 - PubMed
  18. Oncol Rep. 2002 May-Jun;9(3):607-11 - PubMed
  19. J Clin Sleep Med. 2012 Oct 15;8(5):581-3 - PubMed
  20. Hypertension. 2009 Jul;54(1):164-71 - PubMed
  21. J Appl Physiol (1985). 2010 Dec;109(6):1675-85 - PubMed
  22. J Mol Cell Cardiol. 2010 Aug;49(2):210-20 - PubMed
  23. PLoS One. 2014 Apr 09;9(4):e94545 - PubMed
  24. Heart Fail Rev. 2013 Sep;18(5):557-66 - PubMed
  25. J Biol Chem. 2003 Jan 24;278(4):2461-8 - PubMed
  26. Am J Physiol Heart Circ Physiol. 2002 Sep;283(3):H1253-62 - PubMed
  27. Intern Med. 2001 Nov;40(11):1121-7 - PubMed
  28. Exp Mol Pathol. 2013 Feb;94(1):1-9 - PubMed
  29. J Mol Cell Cardiol. 2011 Oct;51(4):600-6 - PubMed
  30. Am J Physiol Heart Circ Physiol. 2010 Sep;299(3):H690-8 - PubMed
  31. J Am Coll Cardiol. 2003 May 7;41(9):1429-37 - PubMed
  32. Biochim Biophys Acta. 2013 Dec;1832(12):2271-6 - PubMed

Publication Types